Clinical Trials Browser

Phase 3 × fosbretabulin × Head & Neck × Clear all

NCT01701349 2014-05-01

FACT2

Phase 3 Withdrawn

EndocrineHead & Neck

Head and Neck Neoplasms, Thyroid Neoplasms, Thyroid Carcinoma, Anaplastic